Headlines about Relx (NYSE:RENX) have been trending somewhat positive on Sunday, Accern Sentiment Analysis reports. Accern identifies positive and negative media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Relx earned a coverage optimism score of 0.07 on Accern’s scale. Accern also gave headlines about the technology company an impact score of 46.4060658656519 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Shares of Relx stock opened at $21.83 on Friday. The firm has a market cap of $20.18 billion, a PE ratio of 20.99, a PEG ratio of 3.62 and a beta of 0.67. The company has a debt-to-equity ratio of 2.39, a quick ratio of 0.37 and a current ratio of 0.41. Relx has a 12 month low of $20.06 and a 12 month high of $23.30.

The company also recently declared a dividend, which will be paid on Wednesday, August 29th. Stockholders of record on Friday, August 3rd will be paid a dividend of $0.139 per share. The ex-dividend date of this dividend is Thursday, August 2nd. This is a positive change from Relx’s previous dividend of $0.14. Relx’s dividend payout ratio (DPR) is currently 26.92%.

A number of analysts have weighed in on the company. Zacks Investment Research upgraded Relx from a “sell” rating to a “hold” rating in a research note on Thursday. UBS Group lowered Relx from a “neutral” rating to a “sell” rating in a research note on Thursday, June 14th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and two have given a buy rating to the company. Relx presently has a consensus rating of “Hold” and a consensus price target of $23.00.

Relx Company Profile

RELX NV, through its interest in RELX Group plc, provides information and analytics for professional and business customers across industries worldwide. It operates through four segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment offers information and analytics to institutions and professionals.

Featured Article: Average Daily Trade Volume – ADTV

Insider Buying and Selling by Quarter for Relx (NYSE:RENX)

Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.